|
1
|
Joyce JA and Pollard JW:
Microenvironmental regulation of metastasis. Nat Rev Cancer.
9:239–252. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dalamaga M, Diakopoulos KN and Mantzoros
CS: The role of adiponectin in cancer: A review of current
evidence. Endocr Rev. 33:547–594. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tan J, Buache E, Chenard MP, Dali-Youcef N
and Rio MC: Adipocyte is a non-trivial, dynamic partner of breast
cancer cells. Int J Dev Biol. 55:851–859. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeong YJ, Bong JG, Park SH, Choi JH and Oh
HK: Expression of leptin, leptin receptor, adiponectin, and
adiponectin receptor in ductal carcinoma in situ and
invasive breast cancer. J Breast Cancer. 14:96–103. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karaduman M, Bilici A, Ozet A, Sengul A,
Musabak U and Alomeroglu M: Tissue levels of adiponectin in breast
cancer patients. Med Oncol. 24:361–366. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morad V, Abrahamsson A and Dabrosin C:
Estradiol affects extracellular leptin:adiponectin ratio in human
breast tissue in vivo. J Clin Endocrinol Metab.
99:3460–3467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Waki H, Yamauchi T, Kamon J, Ito Y, Uchida
S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, et al: Impaired
multimerization of human adiponectin mutants associated with
diabetes. Molecular structure and multimer formation of
adiponectin. J Biol Chem. 278:40352–40363. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pajvani UB, Du X, Combs TP, Berg AH,
Rajala MW, Schulthess T, Engel J, Brownlee M and Scherer PE:
Structure-function studies of the adipocyte-secreted hormone
Acrp30/adiponectin. Implications for metabolic regulation and
bioactivity. J Biol Chem. 278:9073–9085. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fruebis J, Tsao TS, Javorschi S,
Ebbets-Reed D, Erickson MRS, Yen FT, Bihain BE and Lodish HF:
Proteolytic cleavage product of 30-kDa adipocyte complement-related
protein increases fatty acid oxidation in muscle and causes weight
loss in mice. Proc Natl Acad Sci USA. 98:2005–2010. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Waki H, Yamauchi T, Kamon J, Kita S, Ito
Y, Hada Y, Uchida S, Tsuchida A, Takekawa S and Kadowaki T:
Generation of globular fragment of adiponectin by leukocyte
elastase secreted by monocytic cell line THP-1. Endocrinology.
146:790–796. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamashita JI, Ogawa M, Ikei S, Omachi H,
Yamashita SI, Saishoji T, Nomura K and Sato H: Production of
immunoreactive polymorphonuclear leucocyte elastase in human breast
cancer cells: Possible role of polymorphonuclear leucocyte elastase
in the progression of human breast cancer. Br J Cancer. 69:72–76.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Foekens JA, Ries C, Look MP,
Gippner-Steppert C, Klijn JG and Jochum M: The prognostic value of
polymorphonuclear leukocyte elastase in patients with primary
breast cancer. Cancer Res. 63:337–341. 2003.PubMed/NCBI
|
|
13
|
Akizuki M, Fukutomi T, Takasugi M,
Takahashi S, Sato T, Harao M, Mizumoto T and Yamashita J:
Prognostic significance of immunoreactive neutrophil elastase in
human breast cancer: Long-term follow-up results in 313 patients.
Neoplasia. 9:260–264. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu LY, Wang M, Ma ZB, Yu LX, Zhang Q, Gao
DZ, Wang F and Yu ZG: The role of adiponectin in breast cancer: A
meta-analysis. PLoS One. 8:e731832013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Körner A, Pazaitou-Panayiotou K, Kelesidis
T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A,
Tseleni S, Mitsiades N, et al: Total and high-molecular-weight
adiponectin in breast cancer: In vitro and in vivo
studies. J Clin Endocrinol Metab. 92:1041–1048. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo
FC, Fu OY, Chen HY, Hou MF and Yuan SS: Serum adiponectin and
leptin levels in Taiwanese breast cancer patients. Cancer Lett.
237:109–114. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mantzoros C, Petridou E, Dessypris N,
Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C,
Spanos E, Chrousos G and Trichopoulos D: Adiponectin and breast
cancer risk. J Clin Endocrinol Metab. 89:1102–1107. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyoshi Y, Funahashi T, Kihara S, Taguchi
T, Tamaki Y, Matsuzawa Y and Noguchi S: Association of serum
adiponectin levels with breast cancer risk. Clin Cancer Res.
9:5699–5704. 2003.PubMed/NCBI
|
|
19
|
Tworoger SS, Eliassen AH, Kelesidis T,
Colditz GA, Willett WC, Mantzoros CS and Hankinson SE: Plasma
adiponectin concentrations and risk of incident breast cancer. J
Clin Endocrinol Metab. 92:1510–1516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grossmann ME, Nkhata KJ, Mizuno NK, Ray A
and Cleary MP: Effects of adiponectin on breast cancer cell growth
and signaling. Br J Cancer. 98:370–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dos Santos E, Benaitreau D, Dieudonne MN,
Leneveu MC, Serazin V, Giudicelli Y and Pecquery R: Adiponectin
mediates an antiproliferative response in human MDA-MB 231 breast
cancer cells. Oncol Rep. 20:971–977. 2008.PubMed/NCBI
|
|
22
|
Duggan C, Irwin ML, Xiao L, Henderson KD,
Smith AW, Baumgartner RN, Baumgartner KB, Bernstein L,
Ballard-Barbash R and McTiernan A: Associations of insulin
resistance and adiponectin with mortality in women with breast
cancer. J Clin Oncol. 29:32–39. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arditi JD, Venihaki M, Karalis KP and
Chrousos GP: Antiproliferative effect of adiponectin on MCF7 breast
cancer cells: A potential hormonal link between obesity and cancer.
Horm Metab Res. 39:9–13. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Taliaferro-Smith L, Nagalingam A, Zhong D,
Zhou W, Saxena NK and Sharma D: LKB1 is required for
adiponectin-mediated modulation of AMPK-S6K axis and inhibition of
migration and invasion of breast cancer cells. Oncogene.
28:2621–2633. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taliaferro-Smith L, Nagalingam A, Knight
BB, Oberlick E, Saxena NK and Sharma D: Integral role of PTP1B in
adiponectin-mediated inhibition of oncogenic actions of leptin in
breast carcinogenesis. Neoplasia. 15:23–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Treeck O, Lattrich C, Juhasz-Boess I,
Buchholz S, Pfeiler G and Ortmann O: Adiponectin differentially
affects gene expression in human mammary epithelial and breast
cancer cells. Br J Cancer. 99:1246–1250. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo
RL, Wu D, Cooper GJ and Xu A: Adiponectin modulates the glycogen
synthase kinase-3beta/beta-catenin signaling pathway and attenuates
mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res.
66:11462–11470. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dieudonne MN, Bussiere M, Dos Santos E,
Leneveu MC, Giudicelli Y and Pecquery R: Adiponectin mediates
antiproliferative and apoptotic responses in human MCF7 breast
cancer cells. Biochem Biophys Res Commun. 345:271–279. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakayama S, Miyoshi Y, Ishihara H and
Noguchi S: Growth-inhibitory effect of adiponectin via adiponectin
receptor 1 on human breast cancer cells through inhibition of
S-phase entry without inducing apoptosis. Breast Cancer Res Treat.
112:405–410. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pfeiler GH, Buechler C, Neumeier M,
Schäffler A, Schmitz G, Ortmann O and Treeck O: Adiponectin effects
on human breast cancer cells are dependent on 17-beta estradiol.
Oncol Rep. 19:787–793. 2008.PubMed/NCBI
|
|
31
|
Mauro L, Pellegrino M, De Amicis F,
Ricchio E, Giordano F, Rizza P, Catalano S, Bonofiglio D, Sisci D,
Panno ML and Andò S: Evidences that estrogen receptor α interferes
with adiponectin effects on breast cancer cell growth. Cell Cycle.
13:553–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim KY, Baek A, Hwang JE, Choi YA, Jeong
J, Lee MS, Cho DH, Lim JS, Kim KI and Yang Y: Adiponectin-activated
AMPK stimulates dephosphorylation of AKT through protein
phosphatase 2A activation. Cancer Res. 69:4018–4026. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kang JH, Yu BY and Youn DS: Relationship
of serum adiponectin and resistin levels with breast cancer risk. J
Korean Med Sci. 22:117–121. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Macis D, Gandini S, Guerrieri-Gonzaga A,
Johansson H, Magni P, Ruscica M, Lazzeroni M, Serrano D, Cazzaniga
M, Mora S, et al: Prognostic effect of circulating adiponectin in a
randomized 2 × 2 trial of low-dose tamoxifen and fenretinide in
premenopausal women at risk for breast cancer. J Clin Oncol.
30:151–157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Libby EF, Frost AR, Demark-Wahnefried W
and Hurst DR: Linking adiponectin and autophagy in the regulation
of breast cancer metastasis. J Mol Med Berl. 92:1015–1023. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Llanos AA, Dumitrescu RG, Marian C,
Makambi KH, Spear SL, Kallakury BV, Perry DJ, Convit RJ, Platek ME,
Millen AE, et al: Adipokines in plasma and breast tissues:
Associations with breast cancer risk factors. Cancer Epidemiol
Biomarkers Prev. 21:1745–1755. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sonmez B, Seker M, Bilici A, Yavuz Erkal
F, Oven Ustaalioglu BB, Gumus M, Ozturk Guler D, Karaduman M, Gezen
C, Eser M, et al: Is there any correlation among adiponectin levels
in serum, tumor tissue and normal tissue of the same patients with
breast cancer? J BUON. 16:227–232. 2011.PubMed/NCBI
|
|
38
|
Adya R, Tan BK, Chen J and Randeva HS:
Protective actions of globular and full-length adiponectin on human
endothelial cells: Novel insights into adiponectin-induced
angiogenesis. J Vasc Res. 49:534–543. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chedid P, Hurtado-Nedelec M, Marion-Gaber
B, Bournier O, Hayem G, Gougerot-Pocidalo MA, Frystyk J, Flyvbjerg
A, El Benna J and Marie JC: Adiponectin and its globular fragment
differentially modulate the oxidative burst of primary human
phagocytes. Am J Pathol. 180:682–692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ogunwobi OO and Beales IL: Adiponectin
stimulates proliferation and cytokine secretion in colonic
epithelial cells. Regul Pept. 134:105–113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Park M, Youn B, Zheng XL, Wu D, Xu A and
Sweeney G: Globular adiponectin, acting via AdipoR1/APPL1, protects
H9c2 cells from hypoxia/reoxygenation-induced apoptosis. PLoS One.
6:e191432011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hurst DR, Xie Y, Vaidya KS, Mehta A, Moore
BP, Accavitti-Loper MA, Samant RS, Saxena R, Silveira AC and Welch
DR: Alterations of BRMS1-ARID4A interaction modify gene expression
but still suppress metastasis in human breast cancer cells. J Biol
Chem. 283:7438–7444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cody JJ, Markert JM and Hurst DR: Histone
deacetylase inhibitors improve the replication of oncolytic herpes
simplex virus in breast cancer cells. PLoS One. 9:e929192014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Talmadge JE and Fidler IJ: AACR centennial
series: The biology of cancer metastasis: Historical perspective.
Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Klionsky DJ, Abdalla FC, Abeliovich H,
Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M,
Agostinis P, Aguirre-Ghiso JA, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy. Autophagy.
8:445–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mauro L, Pellegrino M, Giordano F, Ricchio
E, Rizza P, De Amicis F, Catalano S, Bonofiglio D, Panno ML and
Andò S: Estrogen receptor-α drives adiponectin effects on cyclin D1
expression in breast cancer cells. FASEB J. 29:2150–2160. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jia Z, Liu Y and Cui S: Adiponectin
induces breast cancer cell migration and growth factor expression.
Cell Biochem Biophys. 70:1239–1245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang R, Wu J, Liu D, Shan H and Zhang J:
Anti-inflammatory effect of full-length adiponectin and
proinflammatory effect of globular adiponectin in esophageal
adenocarcinoma cells. Oncol Res. 21:15–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang R, Yin X, Shi H, Wu J, Shakya P, Liu
D and Zhang J: Adiponectin modulates DCA-induced inflammation via
the ROS/NF-κ B signaling pathway in esophageal adenocarcinoma
cells. Dig Dis Sci. 59:89–97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Habeeb BS, Kitayama J and Nagawa H:
Adiponectin supports cell survival in glucose deprivation through
enhancement of autophagic response in colorectal cancer cells.
Cancer Sci. 102:999–1006. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nepal S, Kim MJ, Lee ES, Kim JA, Choi DY,
Sohn DH, Lee SH, Song K, Kim SH, Jeong GS, et al: Modulation of
Atg5 expression by globular adiponectin contributes to autophagy
flux and suppression of ethanol-induced cell death in liver cells.
Food Chem Toxicol. 68:11–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Nepal S and Park PH: Activation of
autophagy by globular adiponectin attenuates ethanol-induced
apoptosis in HepG2 cells: Involvement of AMPK/FoxO3A axis. Biochim
Biophys Acta. 1833:2111–2125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu J, Xu A, Lam KS, Wong NS, Chen J,
Shepherd PR and Wang Y: Cholesterol-induced mammary tumorigenesis
is enhanced by adiponectin deficiency: Role of LDL receptor
upregulation. Oncotarget. 4:1804–1818. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Vetvik KK, Sonerud T, Lindeberg M, Lüders
T, Størkson RH, Jonsdottir K, Frengen E, Pietiläinen KH and Bukholm
I: Globular adiponectin and its downstream target genes are
up-regulated locally in human colorectal tumors: Ex vivo and
in vitro studies. Metabolism. 63:672–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Delort L, Jardé T, Dubois V, Vasson MP and
Caldefie-Chézet F: New insights into anticarcinogenic properties of
adiponectin: A potential therapeutic approach in breast cancer?
Vitam Horm. 90:397–417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Khan S, Shukla S, Sinha S and Meeran SM:
Role of adipokines and cytokines in obesity-associated breast
cancer: Therapeutic targets. Cytokine Growth Factor Rev.
24:503–513. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Otvos L Jr, Haspinger E, La Russa F,
Maspero F, Graziano P, Kovalszky I, Lovas S, Nama K, Hoffmann R,
Knappe D, et al: Design and development of a peptide-based
adiponectin receptor agonist for cancer treatment. BMC Biotechnol.
11:902011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Gewirtz DA: The four faces of autophagy:
Implications for cancer therapy. Cancer Res. 74:647–651. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Vinayak S and Carlson RW: mTOR inhibitors
in the treatment of breast cancer. Oncology (Williston Park).
27:38–48. 2013.PubMed/NCBI
|
